Drug Profile
S-Metoprolol/clopidogrel
Alternative Names: S-metoprolol extended release/clopidogrel immediate release - EmcureLatest Information Update: 21 May 2015
Price :
$50
*
At a glance
- Originator Emcure Pharmaceuticals
- Class Antihypertensives; Antiplatelets; Class II antiarrhythmics; Heart failure therapies; Ischaemic heart disorder therapies; Propanolamines; Pyridines; Small molecules; Thiophenes
- Mechanism of Action Beta 1 adrenergic receptor antagonists; Platelet aggregation inhibitors; Purinergic P2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cardiovascular disorders; Hypertension; Thrombosis
Most Recent Events
- 24 May 2010 Phase-III clinical trials in Cardiovascular disorders (prevention) in India (PO)
- 24 May 2010 Phase-III clinical trials in Hypertension in India (PO)
- 24 May 2010 Phase-III clinical trials in Thrombosis (prevention) in India (PO)